维普中文期刊产品整合服务
15篇 您的检索式:作者名="HARTMAN T B"
    题名 作者 年代 出处 被引量
1Hesrl and Hesr2 may act as early effectors of Notch signaling in the developing cochlea显示文摘Hayashi T Kokubo H Hartman B H 2008Dev Biol2008,316,1:1
2Designing efficient systems with the equal marginal performance principle 显示文摘HARTMAN T B 2005ASHRAE Journal2005,47,7:1
3All variable speed centrifugal chiller plants显示文摘HARTMAN T B 2001ASHRAEJ2001,43,9:1
4Global optimization strategies for highperformance controls显示文摘Hartman T B 1995ASHARE Transactions1995,101,2:1
5Designing efficient systems with the equal marginal performance principle显示文摘Hartman T B 2005ASHRAE J2005,47,7:1
6Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
7Impact of oxidative stress on female fertility显示文摘Ruder E H Hartman T J Goldman M B 2009Current Opinion in Obstetrics&Gynecology2009,21,3:1
8Synthesis,Anti -HIV Activity, and Metabolic Stability of New Alkenyldiarylmethane HIV -1 Non -Nucleoside Reverse Transcriptase Inhibitors 显示文摘Deng B L Hartman T L Buckheit R W 2005J Med Chem2005,48,:1
9Impact of oxida-tive stress on female fertility显示文摘RUDER E H HARTMAN T J GOLDMAN M B 2009Curr Opin Obstet Gynecol2009,21,3:1
10Early intragastric feeding of seriously burned and long-term ventilated patients a review of 55 patients显示文摘Raff T Hartman B Germann G 1997Burns1997,23,:1
11Impact of oxida-tive stress on femal fertility显示文摘RUDER E H HARTMAN T J GOLDMAN M B 2009Curr Opin Obstet Gynecol2009,21,3:1
12Clear cell renalcell carcinoma with osseous metaplasia: a case report显示文摘Hartman R J Helfand B T Dalton D P 2011Can J Urol2011,18,1:1
13High-functional-avidity cytotoxic T lymphocyte re- sponses to HLA-B-restricted Gag-derived epitopes as- sociated with relative HIV control 显示文摘Berger C T Frahm N Price D A Mothe B Ghebre- michael M Hartman K L Henry L M Brenchley J M Ruff L E Venturi V Pereyra F Sidney J Sette A Douek D C Walker B D Kaufmann D E Brander C 2011J Viral2011,85,18:1
14Presence of the mu3 opiate receptor in endothelial cells:Coupling to nitric oxide production and vasodilation显示文摘STEFANO G B HARTMAN A BILFINGER T V 1995J Biol Chem1995,270,30:1
15Mycobacterium tu- berculosis is extraordinarily sensitive to killing by a vitamin C-in- duced Fenton reaction显示文摘Vilcheze C Hartman T Weinirck B 2013Nature Commun2013,,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费